Cushing’s Syndrome in Children and Adolescents

  • George Mastorakos
  • Christina Kanaka-Gantenbein


Urinary Free Cortisol Adrenocortical Carcinoma Adrenocortical Adenoma Glucocorticoid Excess Pituitary Radiotherapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abad V, Chrousos GP, Reynolds JC, Nieman LK, Hill SC, Weinstein RS, Leong GM (2001) Glucocorticoid excess during adolescence leads to a major persistent deficit in bone mass and an increase in central body fat. J Bone Miner Res 16:1879–1885PubMedGoogle Scholar
  2. 2.
    Covar RA, Leung DYM, McCormick D, Steelman J, Zeitler P, Spahn JD (2000) Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma. J Allergy Clin Immunol 106:651–659CrossRefPubMedGoogle Scholar
  3. 3.
    Cushing H (1912) The pituitary body and its disorders. Lippincott, Philadelphia, pp 219Google Scholar
  4. 4.
    Damiani D, Aguiar CH, Crivellaro CE, Galvao JA, Dichtchekenian V, Setian N (1998) Pituitary macroadenoma and Cushing’s disease in pediatric patients: patient report and review of the literature. J Pediatr Endocrinol Metab 11:665–669PubMedGoogle Scholar
  5. 5.
    De Leon DD, Lange BJ, Walterhouse D, Moshang T (2002) Long-term (15 years) outcome in an infant with metastatic adrenocortical carcinoma. J Clin Endocrinol Metab 87:4452–4456CrossRefPubMedGoogle Scholar
  6. 6.
    Devoe DJ, Miller WL, Conte FA, Kaplan SL, Grumbach MM, Rosenthal SM, Wilson CB, Gitelman SE (1997) Longterm outcome in children and adolescents after transphenoidal surgery in Cushing’s disease. J Clin Endocrinol Metab 82:3196–3202CrossRefPubMedGoogle Scholar
  7. 7.
    Di Somma C, Pivonello R, Loche S, Faggiano A, Klain M, Salvatore M, Lombardi G, Colao A (2003) Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing’s disease: a prospective study. Clin Endocrinol 58:302–308CrossRefGoogle Scholar
  8. 8.
    Dyer EH, Civit T, Visot A, Delande O, Derome P (1994) Transphenoidal surgery for pituitary adenomas in children. Neurosurgery 34:207–212PubMedGoogle Scholar
  9. 9.
    Estrada J, Boronat M, Mielgo M, Magallon R, Millan I, Diez S, Lucas T, Barcelo B (1997) The long-term outcome of pituitary irradiation after unsuccessful transphenoidal surgery in Cushing’s disease. N Engl J Med 336:172–177CrossRefPubMedGoogle Scholar
  10. 10.
    Findlay CA, Macdonald JF, Wallace AM, Geddes N, Donaldson MDC (1998) Childhood Cushing’s syndrome induced by betamethasone nose drops and repeat prescriptions. BMJ 317:739–740PubMedGoogle Scholar
  11. 11.
    Forest MG (2003) Adrenal function tests. In: Ranke MB (ed) Diagnostics of endocrine function in children and adolescents. Karger Verlag, Basel, pp 372–427Google Scholar
  12. 12.
    Fragoso MCBV, Domenice S, Latronico AC, Martin RM, Pereira MAA, Zerbini MCN, Lucon AM, Mendonca BB (2003) Cushing’s syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J Clin Endocrinol Metab 88:2147–2151CrossRefPubMedGoogle Scholar
  13. 13.
    Gafni RI, Papanicolaou DA, Nieman LK (2000) Nighttime salivary cortisol measurement as a simple, noninvasive outpatient screening test for Cushing’s syndrome in children and adolescents. J Pediatr 137:30–35CrossRefPubMedGoogle Scholar
  14. 14.
    Grigsby PW, Thomas PR, Simpson JR, Fineberg BB (1988) Long-term results of radiotherapy in the treatment of pituitary adenomas in children and adolescents. Am J Clin Oncol 11:607–611PubMedGoogle Scholar
  15. 15.
    Hochberg Z (2002) Mechanisms of steroid impairment of growth. Horm Res 58(Suppl 1):33–38CrossRefPubMedGoogle Scholar
  16. 16.
    Hollman GA, Allen DB (1988) Overt glucocorticoid excess due to inhaled corticosteroid therapy. Pediatrics 81:452–5PubMedGoogle Scholar
  17. 17.
    Homer JJ, Gazis TG (1999) Cushing’s syndrome induced by betamethasone nose drops. BMJ 318:1355Google Scholar
  18. 18.
    Hopwood NJ, Kenny FM (1977) Incidence of Nelson’s syndrome after adrenalectomy for Cushing’s disease in children. Am J Dis Child 131:1351–1356Google Scholar
  19. 19.
    Hughes NR, Lissett CA, Shalet SM (1999) Growth hormone status following treatment for Cushing’s syndrome. Clin Endocrinol (Oxf) 51:61–66CrossRefGoogle Scholar
  20. 20.
    Icard P, Goudet P, Charpenay C, Andreassian B, Carnaille B, Chapuis Y, Cougard P, Henry JF, Proye C (2001) Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg 25:891–897CrossRefPubMedGoogle Scholar
  21. 21.
    Johnston LB, Grossmann AB, Plowman PN, Besser GM, Savage MO (1998) Normal final height and apparent cure after pituitary irradiation for Cushing’s disease in childhood: long-term follow-up of anterior pituitary function. Clin Endocrinol 48:663–667CrossRefGoogle Scholar
  22. 22.
    Kernick L, Pieters G, Hermus A, Smals A, Kloppenborg P (1994) Patient’s age is a simple predictive factor for the development of Nelson’s syndrome after total adrenalectomy for Cushing’s disease. J Clin Endocrinol Metab 79:887–889CrossRefPubMedGoogle Scholar
  23. 23.
    Kirk JM, Brain CE, Carson DJ, Hyde JC, Grant DB (1999) Cushing’s syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. J Pediatr 134:789–792PubMedGoogle Scholar
  24. 24.
    Kuwayama A, Kageyama N, Nakane T, Watanabe M, Kanie N (1981) Anterior pituitary function after transphenoidal selective adenomectomy in patients with Cushing’s disease. J Clin Endocrinol Metab 53:165–173PubMedGoogle Scholar
  25. 25.
    Lebrethon MC, Grossman AB, Afshar F, Plowman PN, Besser GM, Savage MO (2000) Linear growth and final height after treatment for Cushing’s disease in childhood. J Clin Endocrinol Metab 85:3262–3265CrossRefPubMedGoogle Scholar
  26. 26.
    Leinung MC, Kane LA, Scheithauer BW, Carpenter PC, Laws ER, Zimmerman D (1995) Long-term follow-up of transphenoidal surgery for the treatment of Cushing’s disease in childhood. J Clin Endocrinol Metab 80: 2475–2479CrossRefPubMedGoogle Scholar
  27. 27.
    Leong GM, Marcado-Asis LB, Reynolds JC, Hill SC, Oldfield EH, Chrousos GP (1996) The effect of Cushing’s disease on bone mineral density, body composition, growth and puberty: a report of an identical twin pair. J Clin Endocrinol Metab 81:1905–1911CrossRefPubMedGoogle Scholar
  28. 28.
    Leung LY, Leung WY, Chan KF, Fan TW, Chung KW, Chan CH (2002) Ruptured adrenocortical carcinoma as a rare cause of paediatric acute abdomen. Pediatr Surg Int 18:730–732PubMedGoogle Scholar
  29. 29.
    Liou LS, Kay R (2000) Adrenocortical carcinoma in children: review and recent innovations. Urol Clin North Am 27:403–421CrossRefPubMedGoogle Scholar
  30. 30.
    Magiakou MA, Mastorakos G, Chrousos GP (1997) Cushing syndrome. Differential diagnosis and treatment. In: Wierman ME (ed) Contemporary endocrinology, vol 3: diseases of the pituitary: diagnosis and treatment. Humana Press, Totowa, NJ, pp 179–202Google Scholar
  31. 31.
    Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler GB, Nieman LK, Chrousos GP (1994) Cushing’s syndrome in children and adolescents — presentation, diagnosis and therapy. N Engl J Med 331: 629–636CrossRefPubMedGoogle Scholar
  32. 32.
    Magiakou MA, Mastorakos G, Gomez MT, Rose SR, Chrousos GP (1994) Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing’s disease before and after surgical cure. J Clin Endocrinol Metab 78:131–137CrossRefPubMedGoogle Scholar
  33. 33.
    Magiakou MA, Mastorakos G, Chrousos GP (1994) Final stature in patients with endogenous Cushing’s syndrome. J Clin Endocrinol Metab 79:1082–1085CrossRefPubMedGoogle Scholar
  34. 34.
    Magiakou MA, Chrousos GP (2002) Cushing’s syndrome in children and adolescents: current diagnostic and therapeutic strategies. J Endocr Invest 25:181–194PubMedGoogle Scholar
  35. 35.
    Martinelli CE Jr, Sader SL, Oliveira EB, Daneluzzi JC, Moreira AC (1999) Salivary cortisol for screening of Cushing’s syndrome in children. Clin Endocrinol (Oxf) 51:67–71CrossRefGoogle Scholar
  36. 36.
    Mathivon L, Carel JC, Coutant R, Derome P, Adamsbaum C, Bougneres P, Chaussain JL (1997) Cushing disease in children and in adolescents. Therapeutic results. Arch Pediatr 4:521–528CrossRefPubMedGoogle Scholar
  37. 37.
    McArthur R, Hayles A, Salassa R (1979) Childhood Cushing disease: results of bilateral adrenalectomy. J Pediatr 95:214–219PubMedGoogle Scholar
  38. 38.
    Newell-Price J, Morris D, Drake W, Korbonits M, Monson JP, Besser GM, Grossman AB (2002) Optimal response criteria for the human corticotrophin-releasing hormone test in the differential diagnosis of ACTH-dependent Cushing’s syndrome. J Clin Endocrinol Metab 87:1640–1645CrossRefPubMedGoogle Scholar
  39. 39.
    Nicholl RM, Kirk JMW, Grossman AB, Plowman PN, Besser GM, Savage MO (1993) Acceleration of pubertal development following pituitary radiotherapy for Cushing’s disease. Clin Oncol 5:393–394Google Scholar
  40. 40.
    Nieman LK, Oldfield EH, Wesley R, Chrousos GP, Loriaux DL, Cutler GB (1993) A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 77:1308–1312CrossRefPubMedGoogle Scholar
  41. 41.
    Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler GB Jr, Loriaux DL (1991) Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing’s syndrome. N Engl J Med 325:897–905PubMedGoogle Scholar
  42. 42.
    Orth DN (1995) Cushing’s syndrome. N Engl J Med 332:791–803CrossRefPubMedGoogle Scholar
  43. 43.
    Ozerdem U, Levi L, Cheng L, Song M-K, Scher C, Freeman WR (2000) Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year old male with posterior uveitis. Am J Ophthalmol 130:240–241CrossRefPubMedGoogle Scholar
  44. 44.
    Raux-Demay MC, Girard F (1993) Adrenal hyperfunction. In: Bertrand J, Rappaport R, Sizonenko PC (eds) Pediatric endocrinology, 2nd edn. Williams and Wilkins, Baltimore, pp 342–350Google Scholar
  45. 45.
    Raux-Demay MC, Girard F (1993) Cushing syndrome in children. Ann Pediatr (Paris) 40:453–462Google Scholar
  46. 46.
    Rogol AD, Hochberg Z (1999) Cushing syndrome. In: Hochberg Z (ed) Practical algorithms in pediatric endocrinology. Karger Verlag, Basel, pp 46–47Google Scholar
  47. 47.
    Sandrini R, Ribeiro RC, De Lacerda L (1997) Childhood adrenocortical tumors. J Clin Endocrinol Metab 82: 2027–2031CrossRefPubMedGoogle Scholar
  48. 48.
    Savage MO, Besser GM (1996) Cushing’s disease in childhood. Trends Endocrinol Metab 7:213–216CrossRefGoogle Scholar
  49. 49.
    Savage MO, Lienhardt A, Lebrethon M-C, Johnston LB, Huebner A, Grossman AB, Afshar F, Plowman PN, Besser GM (2001) Cushing’s disease in childhood: presentation, investigation, treatment and long-term outcome. Horm Res 55(Suppl 1):24–30CrossRefPubMedGoogle Scholar
  50. 50.
    Savage MO, Scommegna S, Carroll PV, Ho JTF, Monson JP, Besser GM, Grossman AB (2002) Growth in disorders of adrenal hyperfunction. Horm Res 58(Suppl 1):39–43CrossRefGoogle Scholar
  51. 51.
    Shalet SM (1986) Pituitary adenomas in childhood. Acta Endocrinol 279(Suppl):434–439Google Scholar
  52. 52.
    Storr HL, Nicholas Plowman P, Carroll PV, Francois I, Krassas GE, Afshar F, Besser GM, Grossman AB, Savage MO (2003) Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing’s disease: an effective second line treatment. J Clin Endocrinol Metab 88:34–37CrossRefPubMedGoogle Scholar
  53. 53.
    Stratakis Ca, Mastorakos G, Magiakou MA, Papavasiliou E, Oldfield EH, Chrousos GP (1997) Thyroid function in children with Cushing’s disease before and after transphenoidal surgery. J Pediatr 131:905–909PubMedGoogle Scholar
  54. 54.
    Stratakis Ca, Kirschner LS (1998) Clinical and genetic analysis of primary bilateral adrenal diseases (micro-and macronodular disease) leading to Cushing syndrome. Horm Metab Res 456–463Google Scholar
  55. 55.
    Stratakis Ca, Mastorakos G, Mitsiades NS, Mitsiades CS, Chrousos GP (1998) Skin manifestations of Cushing disease in children and adolescents before and after the resolution of hypercortisolemia. Pediatr Dermatol 15:253–258PubMedGoogle Scholar
  56. 56.
    Suda T, Demura H, Demura R, Jibiki K, Tozawa F, Shizume K (1980) Anterior pituitary hormones in plasma and pituitaries from patients with Cushing’s disease. J Clin Endocrinol Metab 51:1048–1053PubMedGoogle Scholar
  57. 57.
    Takasu N, Komiya I, Nagasawa Y, Asawa T, Yamada T (1990) Exacerbation of autoimmune thyroid dysfunction after unilateral adrenalectomy in patients with Cushing’s syndrome due to an adrenocortical adenoma. N Engl J Med 322:1708–1712PubMedGoogle Scholar
  58. 58.
    Thomas CG, Smith AT, Benson M et al. (1984) Nelson’s syndrome after Cushing’s disease in childhood: a continuing problem. Surgery 96:1066–1067Google Scholar
  59. 59.
    Trainer PJ, Lawrie HS, Verhelst J, Howlett TA, Lowe DG, Grossman AB, Savage MO, Afshar F, Besser GM (1993) Transphenoidal resection in Cushing’s disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf) 38:73–78Google Scholar
  60. 60.
    Tsagarakis S, Kokoris P, Roboti C, Malagari C, Kaskarelis J, Vlassopoulou A, Alevizaki C, Thalassinis N (1998) The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: Comparisons with clinically euadrenal subjects and patients with Cushing’s syndrome. Clin Endocrinol (Oxf) 48:627–633CrossRefGoogle Scholar
  61. 61.
    Utiger R (1997) Treatment and retreatment of Cushing’s disease. N Engl J Med 336:215–217CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • George Mastorakos
  • Christina Kanaka-Gantenbein

There are no affiliations available

Personalised recommendations